The Journal of Clinical HypertensionVolume 3, Issue 1 p. 59-59 Free Access Book Review First published: 31 May 2007 https://doi.org/10.1111/j.1524-6175.2001.990836.xAboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Hypertension and Co-Existing Disease Francisco Leyve; Andrew Coats Blackwell Science 2000 ; $99.00 ; 230 pages Hypertension and Co-Existing Disease represents a brave attempt at achieving the authors' aim, which is to provide the doctor with a “quick-access guide to specialist advice…. that can be directly applied to individual patients,” and to devise a novel textbook of hypertension that is practical in every sense. The book contains much valuable information that is usefully packaged into tables and diagrams, with a particularly useful one providing an amalgam of the WHO-ISH 19991 and JNC VI2 recommendations on risk stratification and treatment (Figs. 4.2, 8.2). It also summarizes much of the recent literature from major clinical trials, meta-analyses, and epidemiologic studies. Unfortunately, the book suffers from one of the limitations of the genre—it was dated from the minute the manuscript was finished and certainly outdated by the time it was published, distributed, and reviewed. Thus, landmark studies, such as the HOPE Trial3 and the STP2 study4, both first presented or published in 1999, do not enter into the discussion, let alone more recent studies published during 2000, so that by the time a doctor reads this review, the book will be missing about 1 year's new information, and that is a lot in a field where “diagnostic treatment options have proliferated at breakneck speed,” to quote the Preface. The book also falls between two stools, in being longer and harder to use than a “practice manual,” yet too short to provide a truly satisfying review of many aspects of hypertension. The authors' backgrounds as cardiologists show here, as the best and most comprehensive parts of the book are those sections dealing with hypertension and co-existing cardiac disease and with the cardiac manifestations and complications of hypertension. It is less helpful in endocrine aspects of hypertension, and the section on diabetes and hypertension could have been expanded. I suspect that one of the best uses for this publication will be as a reference book for doctors pursuing advanced studies in internal medicine or cardiology and working toward specialist qualification and registration. John Chalmers, MD, AC, FAA, FRACP, Chairman of Research Development, University of Sydney, Sydney Australia. References 1 Guidelines Subcommittee. 1999 World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999; 17: 151– 183. 2 Sixth Report of the Joint National Committee on prevention, detection, Evaluation, and treatment of high blood pressure. Arch Intern Med. 1997: 2413– 2446. 3 Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145– 153. 4 STOP-Hypertension-2 Study Group. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity: The Swedish Trial in Old Patients with Hypertension-2 Study. Lancet. 1999: 1751– 1756. Volume3, Issue1January/February 2001Pages 59-59 ReferencesRelatedInformation